COMPASS Pathways plc
CMPS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816590
No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in COMPASS Pathways plc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +9 vs. Q2 2024
- Shares held
- 32.8M
- +4.65M (+16.5%) vs. Q2 2024
- Total value
- $206.5M
- +$36.5M (+21.5%) vs. Q2 2024
- New holders
- 24
- 27 more added
- Sold out
- 15
- 28 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 224 | $1.28B |
| Q1 2026 | 194 | $511.5M |
| Q4 2025 | 168 | $379.2M |
| Q3 2025 | 157 | $318.0M |
| Q2 2025 | 140 | $145.1M |
| Q1 2025 | 135 | $148.4M |
| Q4 2024 | 132 | $117.0M |
| Q3 2024 | 130 | $206.5M |
| Q2 2024 | 122 | $172.3M |
| Q1 2024 | 116 | $228.1M |
| Q4 2023 | 126 | $201.1M |
| Q3 2023 | 113 | $164.9M |
| Q2 2023 | 97 | $68.7M |
| Q1 2023 | 103 | $81.3M |
| Q4 2022 | 111 | $61.0M |
| Q3 2022 | 115 | $80.2M |
| Q2 2022 | 108 | $73.8M |
| Q1 2022 | 109 | $99.9M |
| Q4 2021 | 126 | $167.0M |
| Q3 2021 | 118 | $228.7M |
| Q2 2021 | 111 | $294.8M |
| Q1 2021 | 83 | $182.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding COMPASS Pathways plc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 229,184 | $1.44M | 0.00% | −119,360−34.2% | Reduced |
| Group One Trading, L.P. | 239,882 | $1.51M | 0.06% | +194,266+425.9% | Added |
| DAFNA Capital Management LLC | 243,210 | $1.53M | 0.36% | 00.0% | Unchanged |
| Shay Capital LLC | 248,076 | $1.56M | 0.46% | −67,000−21.3% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 269,369 | $1.70M | 0.00% | −19,090−6.6% | Reduced |
| Nikko Asset Management Americas, Inc. | 269,369 | $1.70M | 0.02% | −19,090−6.6% | Reduced |
| Founders Fund VII Management, LLC | 278,880 | $1.76M | 100.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 295,785 | $1.81M | 0.00% | +12,599+4.4% | Added |
| Affinity Asset Advisors, LLC | 300,512 | $1.89M | 0.29% | −200,000−40.0% | Reduced |
| Wells Fargo & Company | 301,815 | $1.90M | 0.00% | −1,122−0.4% | Reduced |
| Walleye Capital LLC | 337,456 | $2.13M | 0.02% | +337,456 | New |
| BlackRock, Inc. | 385,409 | $2.43M | 0.00% | +385,409 | New |
| Acuta Capital Partners, LLC | 386,500 | $2.43M | 1.97% | +386,500 | New |
| Barclays PLC | 410,476 | $2.59M | 0.00% | −7,500−1.8% | Reduced |
| Laurion Capital Management LP | 439,311 | $2.77M | 0.18% | −71,596−14.0% | Reduced |
| PFM Health Sciences, LP | 451,267 | $2.84M | 0.16% | −638,325−58.6% | Reduced |
| Woodline Partners LP | 514,418 | $3.24M | 0.03% | +514,418 | New |
| Polar Asset Management Partners Inc. | 567,600 | $3.58M | 0.09% | +258,000+83.3% | Added |
| Rosalind Advisors, Inc. | 781,423 | $4.92M | 3.27% | +47,423+6.5% | Added |
| Sio Capital Management, LLC | 914,639 | $5.76M | 2.58% | +621,222+211.7% | Added |
| Aisling Capital Management LP | 964,500 | $6.08M | 2.33% | 00.0% | Unchanged |
| Morgan Stanley | 1,000,489 | $6.30M | 0.00% | +918,059+1,113.7% | Added |
| Logos Global Management LP | 1,159,030 | $7.30M | 0.82% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,160,000 | $7.31M | 0.26% | −1,175,926−50.3% | Reduced |
| GMT Capital Corp | 1,547,800 | $9.75M | 0.39% | +1,547,800 | New |
| Vivo Capital, LLC | 1,608,000 | $10.1M | 0.84% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,005,125 | $12.6M | 0.12% | −95,386−4.5% | Reduced |
| Millennium Management LLC | 3,756,672 | $23.7M | 0.02% | +374,606+11.1% | Added |
| TCG Crossover Management, LLC | 3,858,000 | $24.3M | 2.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 5,414,576 | $34.1M | 0.04% | +1,746,360+47.6% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −428,708−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −84,415−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −32,497−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −26,607−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,280−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,275−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −12,595−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,920−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,643−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,414−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,141−100.0% | Sold out |
| Camelot Portfolios, LLC | 0 | $0 | 0.00% | −1,112−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −487−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| American Capital Advisory, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |